Dr. Steven N. Zeig

Scott R English MD PA
Pembroke Pines, FL
Specialties:Nephrology
Accepting New Patients
OverviewInsuranceLocationsClinical Research

Overview

Steven Zeig is a Nephrologist in Pembroke Pines, Florida. His top areas of expertise are Chronic Kidney Disease and End-Stage Renal Disease (ESRD). MD. Zeig is currently accepting new patients.

His clinical research consists of co-authoring 9 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Nephrology
Licenses
Internal Medicine in FL
Hospital Affiliations
Memorial Hospital Pembroke
Languages Spoken
English
Spanish
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Health Options
  •  Oscar
  •  UnitedHealthcare
  •  Humana
  •  Florida Blue

Locations

SCOTT R ENGLISH MD PA
2209 N University Dr, Pembroke Pines, FL 33024
954-966-5701
Other Locations
SCOTT R ENGLISH MD PA
16470 Ne 10th Ave, North Miami Beach, FL 33162
305-651-9988

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
Enrollment Status: Completed
Publish Date: April 11, 2024
Intervention Type: Drug
Study Drugs: Bamlanivimab, Etesevimab
Study Phase: Phase 2/Phase 3
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
Enrollment Status: Completed
Publish Date: April 02, 2024
Intervention Type: Drug
Study Drugs: Daprodustat, Darbepoetin Alpha
Study Phase: Phase 3
A 28-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center, Study in Recombinant Human Erythropoietin (rhEPO) naïve Non-dialysis Participants With Anemia Associated With Chronic Kidney Disease to Evaluate the Efficacy, Safety and Effects on Quality of Life of Daprodustat Compared to Placebo
A 28-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center, Study in Recombinant Human Erythropoietin (rhEPO) naïve Non-dialysis Participants With Anemia Associated With Chronic Kidney Disease to Evaluate the Efficacy, Safety and Effects on Quality of Life of Daprodustat Compared to Placebo
Enrollment Status: Completed
Publish Date: April 02, 2024
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo Controlled, Multi-Center Study of a Single Injection Cross-Linked Sodium Hyaluronate Combined With Triamcinolone Hexacetonide (Cingal®) to Provide Symptomatic Relief of Osteoarthritis of the Knee
A Randomized, Double-Blind, Placebo Controlled, Multi-Center Study of a Single Injection Cross-Linked Sodium Hyaluronate Combined With Triamcinolone Hexacetonide (Cingal®) to Provide Symptomatic Relief of Osteoarthritis of the Knee
Enrollment Status: Completed
Publish Date: August 09, 2023
Intervention Type: Drug
Study Drugs: Sodium Hyaluronate, Triamcinolone Hexacetonide
Study Phase: Phase 3
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Anti-Spike SARS-CoV-2 Monoclonal Antibodies as Pre-Exposure Prophylaxis to Prevent COVID-19 in Immunocompromised Participants
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Anti-Spike SARS-CoV-2 Monoclonal Antibodies as Pre-Exposure Prophylaxis to Prevent COVID-19 in Immunocompromised Participants
Enrollment Status: Terminated
Publish Date: July 24, 2023
Intervention Type: Drug
Study Drug: Casirivimab+Imdevimab
Study Phase: Phase 3
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy With Monoclonal Antibodies in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy With Monoclonal Antibodies in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)
Enrollment Status: Completed
Publish Date: July 01, 2022
Intervention Type: Drug
Study Drugs: Bamlanivimab, Etesevimab, LY3853113 Anti-COVID-19 Antibody, VIR-7831 Anti-COVID-19 Antibody
Study Phase: Phase 2
A Multi-Center Open-label Investigation to Assess the Safety and Efficacy of Multiple Doses of DM199 in Patients With Chronic Kidney Disease
A Multi-Center Open-label Investigation to Assess the Safety and Efficacy of Multiple Doses of DM199 in Patients With Chronic Kidney Disease
Enrollment Status: Completed
Publish Date: March 31, 2022
Intervention Type: Drug
Study Drug: DM199
Study Phase: Phase 2
A Randomized, Open-label Study to Evaluate the Effect of Daprodustat on Blood Pressure in Subjects With Anemia Associated With Chronic Kidney Disease on Hemodialysis Switched From a Stable Dose of an Erythropoiesis-stimulating Agent
A Randomized, Open-label Study to Evaluate the Effect of Daprodustat on Blood Pressure in Subjects With Anemia Associated With Chronic Kidney Disease on Hemodialysis Switched From a Stable Dose of an Erythropoiesis-stimulating Agent
Enrollment Status: Completed
Publish Date: June 03, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 7 Less Clinical Trials

9 Total Publications

Impact of Difelikefalin on the Health-Related Quality of Life of Haemodialysis Patients with Moderate-To-Severe Chronic Kidney Disease-Associated Pruritus: A Single-Arm Intervention Trial.
Impact of Difelikefalin on the Health-Related Quality of Life of Haemodialysis Patients with Moderate-To-Severe Chronic Kidney Disease-Associated Pruritus: A Single-Arm Intervention Trial.
Journal: The patient
Published: December 10, 2023
Similar Doctors
Expertise in
10
conditions
Dr. Alessia Fornoni
Nephrology
Expertise in
10
conditions
Dr. Alessia Fornoni
Nephrology

University Of Miami

1611 Nw 12 Ave, 
Miami, FL 
 (16.5 mi)
Languages Spoken:
English, Italian, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Alessia Fornoni is a Nephrologist in Miami, Florida. Dr. Fornoni is highly rated in 10 conditions, according to our data. Her top areas of expertise are Focal Segmental Glomerulosclerosis, Alport Syndrome, Diabetic Nephropathy, Kidney Transplant, and Islet Cell Transplantation. Dr. Fornoni is currently accepting new patients.

Expertise in
9
conditions
Dr. Jochen R. Reiser
Nephrology
Expertise in
9
conditions
Dr. Jochen R. Reiser
Nephrology
1580 Nw 10th Ave, Batch 633a, 
Miami, FL 
 (16.7 mi)
305-243-2349
Languages Spoken:
English
See accepted insurances

Jochen Reiser is a Nephrologist in Miami, Florida. Dr. Reiser is highly rated in 9 conditions, according to our data. His top areas of expertise are Focal Segmental Glomerulosclerosis, Glomerulonephritis, Minimal Change Disease, Nephrotic Syndrome, and Kidney Transplant.

Expertise in
14
conditions
Dr. Adela D. Mattiazzi
Nephrology
Expertise in
14
conditions
Dr. Adela D. Mattiazzi
Nephrology

University Of Miami

1611 Nw 12 Ave, 
Miami, FL 
 (16.5 mi)
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Adela Mattiazzi is a Nephrologist in Miami, Florida. Dr. Mattiazzi is highly rated in 14 conditions, according to our data. Her top areas of expertise are Focal Segmental Glomerulosclerosis, Nephrosclerosis, Diffuse Mesangial Sclerosis, Kidney Transplant, and Simultaneous Pancreas Kidney Transplant. Dr. Mattiazzi is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile